Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial

Yaish, H; Matsushita, T; Belhani, M; Jimenez-Yuste, V; Kavakli, K; Korsholm, L; Matytsina, I; Philipp, C; Reichwald, K; Wu, RH

Yaish, H (corresponding author), Univ Utah, Sch Med, Salt Lake City, UT 84112 USA.

HAEMOPHILIA, 2020; 26 (1): 64

Abstract

Introduction Turoctocog alfa is a recombinant, B domain-truncated factor VIII (FVIII) approved for patients with haemophilia A. Aim To evaluate the sa......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索